 Qualigen Therapeutics Inc NASDAQ:QLGN shares are trading higher after a Zacks Small Cap research note showed a 9 price target on the stock. The report is based on a probability-adjusted DCF model that considers potential future revenues from QN-247 and RAS-F. 